fentanyl

  1. biDOC

    FDA Concerns over TIRF-REMS and Rethinking Access Program

    *TIRF-REMS = Transmucosal Immediate Release Fentanyl - Risk Evaluation and Mitigation Strategy ^Patient, Provider, and Pharmacy is required to register with TIRF-REMS Access Program (e.g. Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys) FDA rethinking TIRF-REMS* after nationally renowned...